Delivery Order SPE2DB22D1200-SPE2DB24FN3UL
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide VYVANSE 30 MG CAPSULE 100S. The delivery order, valued at $1,427.22, is a firm-fixed price contract with a completion date of September 5, 2024. It is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 70 MG CAPSULE 100S. The contract, valued at $4,448.45, is a Firm Fixed Price Delivery Order with a completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will fulfill this order. The...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $2,702.94 and an Ultimate Completion Date of August 6, 2024. The award is not associated with any set-aside program. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of VYVANSE 70 MG CAPSULE 100S pharmaceutical products to the Defense Logistics Agency (DLA). The $5,533.33 Firm Fixed Price delivery order has an ultimate completion date of August 8, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,886,214 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The $1,099.48 firm fixed price award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency of the U.S. Department of Defense, on June 12, 2024 with a completion date of June 13, 2024. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award is a Delivery Order valued at $4,941.93 and has an ultimate completion date of July 10, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The $2,003.28 firm fixed-price delivery order was awarded on May 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award is a Firm Fixed Price delivery order with a ceiling value of $1,454.31 and a period of performance through August 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts...